Adaptive Biotechnologies Corporation at Morgan Stanley Global Healthcare Conference Transcript
Okay. It looks like we're running a couple of minutes behind, so we can quickly get started. Kallum Titchmarsh here from the life science tools and diagnostics team at Morgan Stanley. Really pleased to be joined by the team from Adaptive. We have Chad Robins, Co-Founder and CEO; and Kyle Piskel, CFO.
Thank you both for being here. Just before we get started, research disclosures morganstanley.com/researchdisclosures because someone will tell me off if I don't call that one out.
Questions & Answers
Lots to discuss. Obviously, let's dive into. Maybe we can just start with the state of the union. I know there was also some updates today that you want to hit on out there in the market. So maybe just set the scene.
What is exciting you the most run now, Chad?
Yes. relevant today and kind of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
